1. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications
    Indy Bui et al, 2023, Antioxidants & Redox Signaling CrossRef
  2. A Review of Humoral Factors in Remote Preconditioning of the Heart
    Sergey Y. Tsibulnikov et al, 2019, Journal of Cardiovascular Pharmacology and Therapeutics CrossRef
  3. MicroRNA-29c Acting on FOS Plays a Significant Role in Nonalcoholic Steatohepatitis Through the Interleukin-17 Signaling Pathway
    Chao Cai et al, 2021, Frontiers in Physiology CrossRef
  4. Non-coding RNAs modulate pyroptosis in myocardial ischemia-reperfusion injury: A comprehensive review
    Yi Sun et al, 2024, International Journal of Biological Macromolecules CrossRef
  5. Effect of remote ischemic preconditioning on hepatic ischemia-reperfusion injury in patients undergoing liver resection: a randomized controlled trial
    Guilin Wu et al, 2020, Minerva Anestesiologica CrossRef
  6. Micro RNAs in Regulation of Cellular Redox Homeostasis
    Sylwia Ciesielska et al, 2021, International Journal of Molecular Sciences CrossRef
  7. Fructose Promotion of Intestinal and Liver Injury: A Sugar by Any Other Name That Isn't So Sweet
    Lindsey Kennedy et al, 2021, Hepatology CrossRef
  8. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease
    Meng Zhang et al, 2020, Computational Biology and Chemistry CrossRef
  9. Histone methyltransferase enhancer of zeste 2 polycomb repressive complex 2 subunit exacerbates inflammation in depression rats by modulating microglia polarization
    Xuezhu Huang et al, 2022, Bioengineered CrossRef
  10. Ischemic Preconditioning Directly or Remotely Applied on the Liver to Reduce Ischemia-Reperfusion Injury in Resections and Transplantation
    Maria Eugenia Cornide-Petronio et al, 2019, Liver Disease and Surgery [Working Title] CrossRef
  11. Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions
    Chenggui Miao et al, 2018, Biochemical Genetics CrossRef
  12. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway
    Shoukun Ding et al, 2020, Journal of Pharmacology and Experimental Therapeutics CrossRef
  13. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
    Yunfeng Shen et al, 2023, Metabolism CrossRef